Clinical Trial Update: MDMA-Assisted Psychotherapy in Veterans With Combat-Related, Refractory PTSD [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating MDMA-assisted psychotherapy for veterans with combat-related, refractory PTSD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Combat Stress Disorders
• Post-traumatic Stress Disorder

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: VA Loma Linda Health Care System | Conditions: Post Traumatic Stress Disorder, Combat Stress Disorders | Phase 2 | Status: COMPLETED